Retour
Fourchette du Jour
11,18 €
11,77 €
Fourchette 52 Semaines
9,85 €
17,18 €
Volume
5 366 832
Moyenne 50J / 200J
12,65 €
/
13,23 €
Clôture Précédente
10,95 €
Historique des Prix
Tendances Financières
Comparaison Sectorielle
vs médiane du secteur Healthcare (626 pairs)
| Métrique | Action | Médiane du Secteur |
|---|---|---|
| P/E | -3,9 | 0,4 |
| P/B | 1,7 | 2,9 |
| ROE % | -36,4 | 3,8 |
| Net Margin % | -16,3 | 3,9 |
| Rev Growth 5Y % | -3,4 | 10,0 |
| D/E | 1,8 | 0,2 |
Points Clés
Revenue declined -3,43% annually over 5 years
Generating 104,00M in free cash flow
PEG of 0,12 suggests growth is underpriced
Capital efficient — spends only 3,56% of revenue on capex
ROIC of 4,96% — low return on invested capital
Croissance
Revenue Growth (5Y)
-3,43%
Revenue (1Y)-2,98%
Earnings (1Y)N/A
FCF Growth (3Y)-32,46%
Qualité
Return on Equity
-36,44%
ROIC4,96%
Net Margin-16,25%
Op. Margin6,85%
Sécurité
Debt / Equity
1,84
Current Ratio1,51
Interest Coverage2,86
Valorisation
P/E Ratio
-3,85
P/B Ratio1,72
EV/EBITDA17,65
Dividend Yield0,06%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | -2,98% | Revenue Growth (3Y) | -3,66% |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | -3,43% | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 3,68B | Net Income (TTM) | -598,00M |
| ROE | -36,44% | ROA | -11,01% |
| Gross Margin | 50,00% | Operating Margin | 6,85% |
| Net Margin | -16,25% | Free Cash Flow (TTM) | 104,00M |
| ROIC | 4,96% | FCF Growth (3Y) | -32,46% |
| Safety | |||
| Debt / Equity | 1,84 | Current Ratio | 1,51 |
| Interest Coverage | 2,86 | Dividend Yield | 0,06% |
| Valuation | |||
| P/E Ratio | -3,85 | P/B Ratio | 1,72 |
| P/S Ratio | 0,63 | PEG Ratio | 0,12 |
| EV/EBITDA | 17,65 | Dividend Yield | 0,06% |
| Market Cap | 2,31B | Enterprise Value | 4,45B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 3,68B | 3,79B | 3,97B | 3,92B | 4,23B |
| Net Income | -598,00M | -910,00M | -132,00M | -950,00M | 411,00M |
| EPS (Diluted) | -3,00 | -4,48 | -0,62 | -4,41 | 1,87 |
| Gross Profit | 1,84B | 1,96B | 2,09B | 2,13B | 2,35B |
| Operating Income | 252,00M | -879,00M | -85,00M | -937,00M | 608,00M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 5,43B | 5,75B | 7,37B | 7,64B | 9,24B |
| Total Liabilities | 4,09B | 3,81B | 4,08B | 3,83B | 4,24B |
| Shareholders' Equity | 1,34B | 1,94B | 3,29B | 3,81B | 5,00B |
| Total Debt | 2,47B | 2,27B | 2,30B | 2,15B | 2,29B |
| Cash & Equivalents | 326,00M | 272,00M | 334,00M | 365,00M | 339,00M |
| Current Assets | 2,02B | 1,75B | 1,97B | 1,89B | 1,85B |
| Current Liabilities | 1,34B | 1,59B | 1,43B | 1,17B | 1,26B |